AlphaYouMP
Insider selling
Michael P Dube sold $44K of Intellia Therapeutics, Inc. (NTLA) stock
Michael P Dube, VP, Chief Accounting Officer of Intellia Therapeutics, Inc. (NTLA), sold 2,641 shares of NTLA stock worth $44K, per an SEC Form 4 filed Jul 6, 2026.
It was an open-market sale.
The trade happened on Jul 1, 2026, 5 days before it was made public.
NTLA has moved -26.4% since the trade date, from $17.24 to $12.69 (Sep 22, 2026 close).
- Traded
- Jul 1, 2026
- Disclosed
- Jul 6, 2026
- Filing delay
- 5 days
- Price since
- -26.4%
- Role
- VP, Chief Accounting Officer
- Source
- SEC Form 4
More NTLA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.